Published in Neurol Neurochir Pol on January 07, 2010
Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology (2004) 1.77
Risk factors for falls in stroke patients during inpatient rehabilitation. Clin Rehabil (2009) 1.67
Late-onset Wilson's disease. Gastroenterology (2007) 1.30
The International Stroke Trial database. Trials (2011) 1.28
Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson's disease. J Hepatol (2011) 1.22
Frequency and prognostic value of cognitive disorders in stroke patients. Dement Geriatr Cogn Disord (2008) 1.19
Transcranial magnetic stimulation combined with physiotherapy in rehabilitation of poststroke hemiparesis: a randomized, double-blind, placebo-controlled study. Neurorehabil Neural Repair (2012) 1.02
p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease. Mov Disord (2006) 1.00
Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus. Stroke (2002) 0.97
Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy. Epilepsia (2010) 0.96
Informed consent for clinical trials in acute coronary syndromes and stroke following the European Clinical Trials Directive: investigators' experiences and attitudes. Trials (2008) 0.96
Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease. Acta Neurobiol Exp (Wars) (2003) 0.91
Hyperperfusion syndrome after carotid endarterectomy and carotid stenting. Cerebrovasc Dis (2013) 0.88
Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease. Int Immunopharmacol (2004) 0.87
Pulse pressure--independent predictor of poor early outcome and mortality following ischemic stroke. Cerebrovasc Dis (2008) 0.87
Hepatobiliary malignancies in Wilson disease. Liver Int (2014) 0.87
Left-hand somatosensory stimulation combined with visual scanning training in rehabilitation for post-stroke hemineglect: a randomised, double-blind study. Neuropsychol Rehabil (2008) 0.85
Persistence with treatment in patients with Wilson disease. Neurol Neurochir Pol (2010) 0.85
Effect of low-frequency repetitive transcranial magnetic stimulation on naming abilities in early-stroke aphasic patients: a prospective, randomized, double-blind sham-controlled study. ScientificWorldJournal (2012) 0.85
Prevention of ischemic stroke in clinical practice: a role of internists and general practitioners. Pol Arch Med Wewn (2014) 0.84
Concordance rates of Wilson's disease phenotype among siblings. J Inherit Metab Dis (2013) 0.83
Effects of repeated anodal tDCS coupled with cognitive training for patients with severe traumatic brain injury: a pilot randomized controlled trial. J Head Trauma Rehabil (2014) 0.83
Transcranial magnetic stimulation combined with speech and language training in early aphasia rehabilitation: a randomized double-blind controlled pilot study. Top Stroke Rehabil (2013) 0.82
Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis. Med Sci Monit (2003) 0.82
Neuropsychological and neurological sequelae of out-of-hospital cardiac arrest and the estimated need for neurorehabilitation: a prospective pilot study. Kardiol Pol (2014) 0.82
Agreement between the clinical Oxfordshire Community Stroke Project classification and CT findings in Poland. Eur J Neurol (2004) 0.82
Weekend versus weekday admissions in Polish stroke centres -- could admission day affect prognosis in Polish ischaemic stroke patients? Neurol Neurochir Pol (2012) 0.82
Infections and ischemic stroke outcome. Neurol Res Int (2011) 0.82
Ibuprofen and the mouse model of Parkinson's disease. Ann Neurol (2006) 0.81
[Wilson disease - factors affecting clinical presentation]. Neurol Neurochir Pol (2013) 0.81
Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on the age at onset of neuropsychiatric symptoms in Wilson's disease. Int J Neurosci (2010) 0.81
Association between BDNF-196 G>A and BDNF-270 C>T polymorphisms, BDNF concentration, and rTMS-supported long-term rehabilitation outcome after ischemic stroke. NeuroRehabilitation (2013) 0.81
Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease. Biometals (2013) 0.80
Liver cirrhosis in patients newly diagnosed with neurological phenotype of Wilson's disease. Funct Neurol (2014) 0.80
Influence of age and gender on cytokine expression in a murine model of Parkinson's disease. Neuroimmunomodulation (2008) 0.80
Anodal transcranial direct current stimulation in early rehabilitation of patients with post-stroke non-fluent aphasia: a randomized, double-blind, sham-controlled pilot study. Restor Neurol Neurosci (2013) 0.79
Efficacy of Nitric Oxide in Stroke - a randomized trial. Characteristics of patients recruited in Poland. Neurol Neurochir Pol (2008) 0.79
Incidence and case fatality rates of first-ever stroke - comparison of data from two prospective population-based studies conducted in Warsaw. Neurol Neurochir Pol (2011) 0.79
Acute respiratory distress syndrome as a manifestation of brain stem tumour--a case report. Neurol Neurochir Pol (2010) 0.79
Self-rated emotional functioning of patients with neurological or asymptomatic form of Wilson's disease. Clin Neuropsychol (2003) 0.79
Care for patients after stroke. Results of a two-year prospective observational study from Mazowieckie province in Poland. Neurol Neurochir Pol (2010) 0.79
Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse. Brain Res (2004) 0.79
Knowledge of risk factors and stroke symptoms among nonstroke patients. Eur Neurol (2012) 0.79
[Influence of transcranial direct current stimulation on cognitive functioning of patients with brain injury]. Neurol Neurochir Pol (2011) 0.79
Acute ischemic stroke care and outcome in centers participating in the Polish National Stroke Prevention and Treatment Registry. Stroke (2006) 0.77
Prestroke antihypertensive therapy: effect on the outcome. Clin Exp Hypertens (2012) 0.77
Families with Wilson's disease in subsequent generations: clinical and genetic analysis. Mov Disord (2014) 0.77
Thrombolysis in acute ischaemic stroke within 3 hours of symptom onset: a report of the first 100 cases. Neurol Neurochir Pol (2008) 0.77
APOE does not predict poor outcome 1 year after ischemic stroke. Neurol Res (2007) 0.77
Wilson's disease: does iron metabolism impact phenotypic presentation? Liver Int (2012) 0.77
Dopamine, serotonin and noradrenaline changes in the striatum of C57BL mice following myelin oligodendrocyte glycoprotein (MOG) 35-55 and complete Freund adjuvant (CFA) administration. Acta Neurobiol Exp (Wars) (2007) 0.77
Intravenous thrombolysis for acute ischaemic stroke in patients not fully adhering to the European licence in Poland. Neurol Neurochir Pol (2012) 0.77
Neurological presentation of Wilson's disease in a patient after liver transplantation. Mov Disord (2008) 0.76
Organization of acute stroke services in Poland - Polish Stroke Unit Network development. Neurol Neurochir Pol (2013) 0.76
Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease. Pharmacol Rep (2013) 0.76
Does brain degeneration in Wilson disease involve not only copper but also iron accumulation? Neurol Neurochir Pol (2013) 0.76
Changes of percentages in immune cells phenotypes and cytokines production during two-year IFN-beta-1a treatment in multiple sclerosis patients. J Neurol (2003) 0.76
Gene variants encoding proteins involved in antioxidant defense system and the clinical expression of Wilson disease. Liver Int (2014) 0.76
Intestinal expression of metal transporters in Wilson's disease. Biometals (2013) 0.75
Successful treatment with intravenous recombinant tissue plasminogen activator in an acute stroke patient presenting with hemiballism. Funct Neurol (2015) 0.75
Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease. Funct Neurol (2016) 0.75
Venous thromboembolism prophylactic methods in acute stroke patients - current state of knowledge. Neurol Neurochir Pol (2013) 0.75
Preface. Handb Clin Neurol (2017) 0.75
Pharmacotherapy prior to and in acute ischaemic stroke. The use of pharmacotherapy and drug-associated outcomes in real world practice - findings from the Polish Hospital Stroke Registry. Neurol Neurochir Pol (2013) 0.75
Ultrastructural picture of blood vessels in muscle and skin biopsy in CADASIL. Folia Neuropathol (2006) 0.75
[Prognostic factors in the acute phase of haemorrhagic stroke]. Neurol Neurochir Pol (2002) 0.75
Co-existing spinal canal tumours and CADASIL - a diagnostic challenge. Neurol Neurochir Pol (2007) 0.75
Brain proton magnetic spectroscopy in long-term treatment of Wilson's disease patients. Metab Brain Dis (2010) 0.75
Heterozygous carriers for Wilson's disease--magnetic spectroscopy changes in the brain. Metab Brain Dis (2009) 0.75
Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome. Thromb Haemost (2017) 0.75
Lenticular nucleus hyperechogenicity in Wilson's disease reflects local copper, but not iron accumulation. J Neural Transm (Vienna) (2014) 0.75
[Pain in the course of multiple sclerosis]. Neurol Neurochir Pol (2002) 0.75
Abnormal antisaccades and smooth pursuit eye movements in patients with Wilson's disease. Mov Disord (2008) 0.75
[Coronary artery bypass surgery in patients with symptomatic or asymptomatic internal carotid artery stenosis]. Neurol Neurochir Pol (2009) 0.75
Down-regulation of microglia and NG2-positive cells reaction in trimethyltin-injured hippocampus of rats treated with myelin basic protein-reactive T cells: possible contribution to the neuroprotective effect of T cells. J Neurosci Res (2010) 0.75
Polish Forum for Prevention Guidelines on Cardiovascular Risk Assessment: update 2016. Kardiol Pol (2017) 0.75
Widespread subcutaneous haematoma after thrombolytic therapy in stroke patients. Mild falls at stroke onset may be dangerous. Neurol Neurochir Pol (2007) 0.75
Are cognitive and behavioural deficits a part of the clinical picture in Kennedy's disease? A case study. Neurocase (2009) 0.75
Polish Forum for Prevention Guidelines on Dyslipidaemia: update 2016. Kardiol Pol (2017) 0.75
Development of the stroke unit network in Poland--current status and future requirements. Neurol Neurochir Pol (2007) 0.75
[Rules of application and mode of action of transcranial direct current stimulation in neurorehabilitation: primary motor cortex]. Neurol Neurochir Pol (2010) 0.75
[Botulinum toxin type A in the management of spasticity in adults: recommendations of an interdisciplinary group of experts]. Neurol Neurochir Pol (2005) 0.75
TMS-induced motor evoked potentials in Wilson's disease: a systematic literature review. Bioelectromagnetics (2015) 0.75
Positivity of serum "classical" onconeural antibodies in a series of 2063 consecutive patients with suspicion of paraneoplastic neurological syndrome. J Neuroimmunol (2013) 0.75
[Prevalence of the metabolic syndrome in ischaemic stroke population]. Neurol Neurochir Pol (2007) 0.75
APOE genotype and serum cholesterol in predicting risk for early death from ischemic stroke in men and women. Cerebrovasc Dis (2005) 0.75
Pharmacotherapy prior to and in acute haemorrhagic stroke. The use of pharmacotherapy and drugs associated outcomes in real-world practice - findings from the Polish Hospital Stroke Registry. Neurol Neurochir Pol (2013) 0.75
[The role of inflammatory reaction in Alzheimer's disease and neurodegenerative processes]. Neurol Neurochir Pol (2002) 0.75
Polish Forum for Prevention Guidelines on Hypertension: update 2017. Kardiol Pol (2017) 0.75
[Estimation of patient eligibility for thrombolysis in acute ischaemic stroke based on a hospital stroke registry in Warsaw]. Neurol Neurochir Pol (2006) 0.75
Mechanical embolectomy in acute ischaemic stroke--report of the first two cases. Neurol Neurochir Pol (2008) 0.75
Polish Forum for Prevention Guidelines on Smoking: update 2017. Kardiol Pol (2017) 0.75
Echolucent internal carotid artery plaques are a risk factor for stroke. Neurol Neurochir Pol (2008) 0.75
Alternative methods of treatment used by multiple sclerosis patients in Poland. Neurol Neurochir Pol (2006) 0.75